Status:
COMPLETED
Cohort of Patients With Inflammatory Bowel Disease During COVID-19 Pandemic
Lead Sponsor:
Nantes University Hospital
Conditions:
IBD
COVID
Eligibility:
All Genders
18-100 years
Brief Summary
Multicenter cohort of patients followed for 6 months during the pandemic in France with biocollection of sera and peripheral blood mononuclear cells
Detailed Description
Multicenter cohort of patients followed for 6 months during the pandemic in France with biocollection of sera and peripheral blood mononuclear cellsNo data has been published concerning the incidence ...
Eligibility Criteria
Inclusion
- adult patients (\>18 years), know Crohn's disease or ulcerative colitis, treated by infliximab or vedolizumab
Exclusion
- not affiliated to a sanitary social insurance
Key Trial Info
Start Date :
March 30 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 18 2021
Estimated Enrollment :
1109 Patients enrolled
Trial Details
Trial ID
NCT04344249
Start Date
March 30 2020
End Date
February 18 2021
Last Update
March 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Nantes
Nantes, France